Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 2

2(40.0%)

5Total

N/A(3)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT02968069Not ApplicableNot Yet Recruiting

A Predictive Model Based on Narrow Band Imaging for Early Gastric Cancerous Lesions

Role: collaborator

NCT06078995Unknown

Tenecteplase Thrombolytic Therapy for Acute Ischemic Stroke in China

Role: collaborator

NCT01844050Not ApplicableCompleted

Traditional Chinese Medicine in Individualized Treatment of Patients With Diabetes Symptoms

Role: collaborator

NCT01805765Phase 2Completed

Qing'E Formula Therapy on Menopausal Symptoms

Role: collaborator

NCT02610595Not ApplicableUnknown

Study on the Therapeutic Effect of TCM Treatment for MDR MN

Role: collaborator

NCT01492556Phase 2Unknown

Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer

Role: collaborator

All 6 trials loaded